Table 4.
Variables | Category | Frequency (%) |
---|---|---|
Experience of opportunistic infection | Yes | 285(66.0) |
No | 145(34.0) | |
Recent adherence level | Good | 390(91.3) |
Fair | 12(2.8) | |
Poor | 25(5.9) | |
Missed appointment | No missed appointment | 286(67.0) |
1 to 4 appointments | 98(23.0) | |
≥ 4 appointments | 43(10.0) | |
First line regimen change | Yes | 162(37.9) |
No | 265(62.3) | |
Latest BMI before failure | ≤18.4 kg/m2 | 75(17.6) |
18.5–24.9 kg/m2 | 329(77.0) | |
≥25 kg/m2 | 23(5.4) | |
Number of EAC session | 3 sessions | 239(55.7) |
4–6 sessions | 188(44.3) | |
History of CPT provision stats | Provided | 164(39.0) |
On-going | 184(43.7) | |
Not Provided | 73(17.3) | |
History of TPT provision status | Completed | 310(72.6) |
Discontinued | 19(4.5) | |
On-going | 11(2.6) | |
Not Provided | 87(20.4) | |
Ever enrolled to ASM | Yes | 31(7.3) |
No | 393(92.7) | |
Duration between 1st and 2nd HVL | Less than 6 months | 145(34.0) |
6–12 months | 152(35.6) | |
≥12 months | 130(30.4) | |
Duration on first line ART before failure | <4 years | 87(20.4) |
5–8 years | 182(42.6) | |
≥8 years | 158(37) | |
Viral load count at failure | 1001–10,000 copy/mL | 138(32.3) |
10,001–60,000 copy/mL | 183(42.9) | |
≥60,000 copy/mL | 106(24.8) |
Abbreviations: ASM, appointment spacing model; HVL, high viral load; EAC, enhanced adherence counseling; TPT, TB preventive therapy; BMI, body mass index; CPT, cotrimoxazole preventive therapy; ART, anti-retroviral therapy.